Literature DB >> 20204315

[Pedunculated osteoma of the frontal sinus].

P Baumeister1, M Niederhagen, E Krause.   

Abstract

Osteoma, the most frequent tumor of the paranasal sinuses (PNS), is often asymptomatic. Men are more commonly affected than women. A 52-year-old patient complained of increasing incidence of headaches following the resolution of frontal sinusitis. Computer tomography demonstrated a pedunculated osteoma of the frontal sinus. Histomorphologically, PNS osteomas usually show cortical bone differentiation with sparse medullary space and a lamellar configuration. At 6 months following surgical resection, the patient was still symptom-free.

Entities:  

Mesh:

Year:  2010        PMID: 20204315     DOI: 10.1007/s00106-009-2062-5

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  6 in total

1.  Frontoethmoid osteoma.

Authors:  R H Vowles; N R Bleach
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-05       Impact factor: 1.547

Review 2.  Common fibro-osseous lesions of the paranasal sinuses.

Authors:  Robert Eller; Michael Sillers
Journal:  Otolaryngol Clin North Am       Date:  2006-06       Impact factor: 3.346

3.  Fibrous dysplasia and ossifying fibroma of the paranasal sinuses.

Authors:  D J Commins; N S Tolley; C A Milford
Journal:  J Laryngol Otol       Date:  1998-10       Impact factor: 1.469

Review 4.  Peripheral osteoma of the oral and maxillofacial region: a study of 35 new cases.

Authors:  Nejat Bora Sayan; Cahit Uçok; Hakan Alpay Karasu; Omer Günhan
Journal:  J Oral Maxillofac Surg       Date:  2002-11       Impact factor: 1.895

5.  Paranasal sinus osteomas and Gardner's syndrome.

Authors:  Alan A Z Alexander; Alpen A Patel; Rick Odland
Journal:  Ann Otol Rhinol Laryngol       Date:  2007-09       Impact factor: 1.547

6.  Endonasal endoscopic resection of ethmoido-orbital osteoma compressing the optic nerve.

Authors:  Mohsen Naraghi; Arash Kashfi
Journal:  Am J Otolaryngol       Date:  2003 Nov-Dec       Impact factor: 1.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.